Adalimumab

Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).
Read more
€0.00 (tax incl.)
Reference:
HY-P9908
Product Details
HY-P9908

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor; Bacterial
Application
COVID-19-immunoregulation
CAS
331731-18-1

Menu

Settings